Digital payments platform Razorpay has acquired mobile point-of-sale device provider Ezetap, marking its third acquisition this year. Separately, healthcare-focused fund Quadria Capital plans to sell its entire 20% stake in active pharmaceutical ingredients (API) maker Concord Biotech.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
